Granules India Limited (IN:GRANULES)
:GRANULES
Want to see IN:GRANULES full AI Analyst Report?
GRANULES Stock Chart & Stats
₹615.10
₹1.80(0.30%)
At close: 4:00 PM EST
₹615.10
₹1.80(0.30%)
Day’s Range― - ―
52-Week Range₹433.00 - ₹772.85
Previous CloseN/A
Volume528.44K
Average Volume (3M)56.05K
Market Cap
₹187.93B
Enterprise Value₹193.62B
Total Cash (Recent Filing)₹6.26B
Total Debt (Recent Filing)₹18.07B
Price to Earnings (P/E)18.8
Beta1.00
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)21.14
Shares Outstanding247,796,920
10 Day Avg. Volume60,875
30 Day Avg. Volume56,048
Financial Highlights & Ratios
PEG Ratio1.39
Price to Book (P/B)2.97
Price to Sales (P/S)2.81
P/FCF Ratio125.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹694.00Price Target Upside12.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)31.98
Revenue Forecast (FY)₹62.13B
Bulls Say, Bears Say
Bulls Say
Vertical IntegrationVertical integration across APIs, PFIs and FDF gives durable cost and supply advantages: it captures margin across the value chain, secures inputs, supports scale manufacturing and repeat B2B contracts, and raises barriers to entry—helpful for multi-month resilience.
Revenue RecoveryResumption of revenue growth after two flat years signals recovering end-market demand and better capacity utilization. Sustained mid-single to double-digit top-line growth can underpin stable cash generation and provide runway to absorb fixed costs over the coming months.
Conservative LeverageModerate debt-to-equity is conservative for a manufacturing business, preserving financial flexibility. Reasonable leverage reduces refinancing risk, supports continued capex or working-capital funding, and gives management room to invest or respond to industry shocks.
Bears Say
Margin PressureGross-profit decline while revenue rose suggests structural cost inflation or adverse product mix and weakening pricing power. Persistent margin compression reduces operating leverage, erodes earnings quality and limits ability to convert revenue gains into sustainable profit growth.
Uneven Cash ConversionVolatile and weakening free cash flow versus net income signals working-capital drains or rising capex needs. Uneven cash conversion constrains self-funding for growth, limits discretionary returns to shareholders and raises reliance on external financing over the medium term.
Declining ROEA material fall in ROE indicates lower capital efficiency: either higher capital intensity or weaker operating margins. If this persists, it signals diminishing returns on incremental investment and challenges for management to restore historical profitability levels.
Granules India Limited News
GRANULES FAQ
What was Granules India Limited’s price range in the past 12 months?
Granules India Limited lowest stock price was ₹433.00 and its highest was ₹772.85 in the past 12 months.
What is Granules India Limited’s market cap?
Granules India Limited’s market cap is ₹187.93B.
When is Granules India Limited’s upcoming earnings report date?
Granules India Limited’s upcoming earnings report date is Aug 12, 2026 which is in 83 days.
How were Granules India Limited’s earnings last quarter?
Granules India Limited released its earnings results on Apr 29, 2026. The company reported ₹7.6 earnings per share for the quarter, beating the consensus estimate of ₹6.05 by ₹1.55.
Is Granules India Limited overvalued?
According to Wall Street analysts Granules India Limited’s price is currently Undervalued.
Does Granules India Limited pay dividends?
Granules India Limited pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.24%. See more information on Granules India Limited dividends here
What is Granules India Limited’s EPS estimate?
Granules India Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Granules India Limited have?
Granules India Limited has 247,796,920 shares outstanding.
What happened to Granules India Limited’s price movement after its last earnings report?
Granules India Limited reported an EPS of ₹7.6 in its last earnings report, beating expectations of ₹6.05. Following the earnings report the stock price went up 0.078%.
Which hedge fund is a major shareholder of Granules India Limited?
Currently, no hedge funds are holding shares in IN:GRANULES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
GRANULES Stock 12 Month Forecast
Average Price Target
₹694.00
▲(12.83% Upside)
Technical Analysis
Alembic Pharmaceuticals Limited
―
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Glenmark Pharmaceuticals Limited
―
Sanofi India Limited
―